NCT04881240
- Conditions
- Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, +11 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Clinical trial condition
Acute Lymphoblastic Leukemia, Refractory
Explore clinical trials studying Acute Lymphoblastic Leukemia, Refractory. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Acute Lymphoblastic Leukemia, Refractory trial results
Active, Not Recruiting
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
NCT03573700
- Conditions
- Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, +15 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States